ABSTRACT Noroviruses (NoV) are identified as the major cause of epidemic and sporadic acute gastroenteritis. Controlling the spread of the disease needs early recognition of NoV. This study investigated the contribution of norovirus to sporadic cases of pediatric gastroenteritis in Zagazig University Hospitals and studied the performance characteristics of enzyme linked immunosorbent assay(EIA) and immunochromatographic (ICT) assay for their ability to detect NoV. Two hundred stool specimens were collected from pediatric patients with acute gastroenteritis. Samples were tested for Norovirus presence by reverse transcription PCR (RT-PCR), ICT kit and EIA. 27% of the samples showed the 338-bp portion of the RNA-dependent RNA polymerase (RdRp) gene of both Norovirus genogroups I and II by RT-PCR. The ICT assay showed high specificity (97.94%) and high sensitivity (85.18%). The EIA showed high specificity (93.8%) but low sensitivity (64.8%). In conclusion, the high detection rate of NoV as the cause of diarrhea in children reported in this study supports their addition in screenings to identify sporadic cases of acute gastroenteritis. The ICT and RIA Norovirus kits may be useful for rapid screening of stool samples from patients with acute gastroenteritis. However, RT-PCR should be considered for negative samples to be confirmed. 
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INTRODUCTION
Norovirus (NoV) is an important cause of acute nonbacterial gastroenteritis in children and adults worldwide. NoV is classified in the Calicivirus family which includes vesivirus, lagovirus, and sapovirus. The genome of caliciviruses is single-stranded, positive-sense RNA, 7.5 kb approximately, which are arranged into three open reading frames (ORFs) that encode the nonstructural proteins (ORF1), a capsid protein (ORF2), and a small basic protein (ORF3) (1).
Improved diagnostics of NoV have increased its identification to become the leading cause of epidemic and sporadic gastroenteritis in people of all age groups worldwide (2) . Most of NoV outbreaks take place in hospitals, wherethe virus is mainly transmitted from one person to another. In addition, noroviruses have also been diagnosed in over 58% of the announced food borne outbreaks in which an etiologic agent was identified (3). NoV, except of murine strains, cannot be cultivated in vitro, which makes their classification into distinct serotypes very difficult. Consequently, they are genetically classified into 6 recognised geno-groups (GI to GVI) (4).
Early recognition of NoV is important to decrease the transmission of disease in outbreaks (5) . Norwalk virus was discovered in 1972 by electron microscopy, then cloning and sequencing in 1990 occur. Diagnosis of NoV was done by conventional reverse RT-PCR assay in the mid-1990s followed by real-time RT-PCR (rRT-PCR) assays, which is now the method used for diagnosis of NoV in most clinical laboratories (6) .The role of NoV as an important cause of both epidemic and sporadic gastroenteritis were better understood using molecular techniques and sequence analysis (7). Wide differences within this genus were detected using genomic analysis. These diversity are present even in the (RdRp) gene, which is supposed to be conserved. RdRp gene is used not only for the identification of gastroenteritis caused by NoVs, but also for molecular and epidemiological studies of calicivirus infections because of its lower diversity (8) .
Rapid detection of NoV using various kits have been established lately and are commercially available such as enzyme EIAs and ICT tests. Large-scale clinical and epidemiological studies can use these kits. These kits require antibodies that cross react between NoV genogroups to overcome the high antigenic diversity of NoVs and help to detect new strains. The usefulness of these kits for routine screening of samples should be investigated because the sensitivity and specificity of NoV diagnostic kits vary with the diagnostic goal (outbreak or sporadic cases) and test design (6) .
The aim of the present study was to investigate the contribution of NoV to sporadic cases of pediatric gastroenteritis in Zagazig University Hospitals and to evaluate the IDEIA norovirus assay (Oxoid, UK) together with a second assay, RIDA quick Norovirus Test (R-BioPharm, Darmstadt, Germany), for their capability to detect NoV antigen in faecal samples by comparing the obtained results with RT-PCR results.
MATERIALS AND METHODS Stool samples.
Two hundred stool specimens were collected at Zagazig University Hospitals, Egypt, from 1-monthold to 12-year-old patients who visited the clinics for acute gastroenteritis from November 2014 to June 2015. Specimens were collected within 72 h following the onset of symptoms. Samples were routinely tested for the presence of bacterial infections and fecal leukocytes in the Microbiology and Immunology Department, Faculty of Medicine, Zagazig University. Sample preparation and RNA extraction Stool suspensions (10%) were prepared in phosphatebuffered saline (pH 7.2 to 7.4) by standard methods as soon as they arrive to the laboratory.Isolation of RNA from 140µl stool extracts was done using QIAmpmicrospin columns (viral RNA minikit; QIAGEN)according to the manufacturer's protocols. Aliquots containing the eluted RNA in 60 µl of elution buffer were stored at -20°C until testing. If the IDEIA Norovirus testwas going to be done in a maximum of 3 days, specimens were stored at 2-8°C.Faecal specimens were kept at -20°Cin case of longer storage.
RT-PCR
Testing stool specimens for NoV was conducted by nested RT-PCR, using the primer pair NV32 (5'-4226-4245 ATG AAT ATG AATGAA GAT GG-3') and NV36 (5'-4707-4726 ATT GGT CCT TCT GTT TTGTC-3') for first-round amplification and primer pair NV33 (5'-4280-4299 TACCAC TAT GAT GCA GAT TA-3') and NV35 (5'-4617-4636 GTT GAC ACAATC TCA TCA TC-3') for second-round amplification (9) . These primers amplified theRdRp gene of both genogroups I and II with a final product of338-bp band.
Five microliter of extracted RNA was added to a 15µl mix consisting of 10 mM Tris-HCl (pH 8.3), 5 mM MgCl2, 50 mM KCl, deoxynucleoside triphosphate at a concentration of 1mM each, together with 20 U of avian myeloblastoma virus reverse transcriptase (Roche Applied Science, Mannheim, Germany). Reverse transcription cycles were conducted as follow: 10 min at 25°C , then60 min at 42°C, finally, the reaction was stopped using denaturing the enzyme for 5 min at 98°C then cooling of the mixture down to 4°C was done. The resulting cDNA (2µl) was added to the PCR mix(48 µl) in a 50µl reaction mixture consisting of 10 mM Tris-HCl, 1.25 mM MgCl2, 50 mM KCl, 2.5 U of Taq polymerase (Roche Applied Science, Mannheim, Germany), 30 pmol each of the NV32 and NV36 primers and each deoxynucleoside triphosphate at a concentration of 125 µM. Amplification was done according to the following cycles: primary denaturation at 94°C for 60 s; 35 cycles of denaturation at 94°C for 30 s, annealing at 42°C for 30 s, and extension at 72°C for 45 s; and a final extension at 72°C for 3 min. One microliter of the first PCR product was used in the nested PCR under similar reaction conditions with primers NV33and NV35. Examination of final product was done by gel electrophoresis in 2% agarose gels containing ethidium bromide (8) .
The RIDA QUICK Norovirus Test. (R-Biopharm, Darmstadt, Germany). Rida quick Norovirus Test was used for antigen detection in stool suspension according to the manufacturer protocols. The Test which can determine GI and GII noroviruses in stool samples is a quick qualitative immunochromatographic test. It helps in the diagnosis of gastroenteritis and for the analysis of stool samples from pediatric and adult patients suspected to have gastroenteritis caused by NoV.
This assay employed both biotinylated and goldlabeled anti-norovirus antibodies for quick diagnosis. Immune complexes are formed between NoV and the gold-labeled anti-norovirus antibodies and migrate through the reaction membrane in positive samples.The migrating immune complexes are captured by streptavidin at the test line (T line) via the biotin joined to the anti-norovirus antibodies, and the T line is stained in red violet colour. Gold-labeled antibodies which is not bound in the complex migrate and captured at the control line (C line). In negative samples, the binding of gold-labeled immunocomplexes will occur only at the C line but not at the T line. Validation of the test is confirmed by the presence of a red C line.
The IDEIA Norovirus test (Oxoid, UK).
IEA was done to identify NoV antigen in 10% stool suspension according to the manufacturer protocols. The IDEIA Norovirus test detect GI and GII NoV utilising a combination of both GI and GII specific polyclonal andmonoclonal antibodies fixed in a solid phase sandwich enzyme immunoassay. A mixture of genogroup 1 and genogroup 2 NoV specific monoclonal antibodies are coating micowells. Control or faecal suspension is added to the microwell and incubated simultaneously with a mixture of NoV specific GI and GII polyclonal and monoclonal antibodies conjugated to horseradish peroxidase. Capturing of Norovirus antigen present in the specimen takes place between solid phase antibodies and the enzyme conjugated antibodies. Microwells are washed with wash buffer to remove any unbound enzyme labeled antibodies and excess specimenafter60 minutes incubation at room temperature. After adding chromogen, the microwells is incubated for 30 minutes at room temperature. A colour change will occur in the presence of specifically bound enzyme labelled antibodies in the microwells, which is stopped by the addition of acid. The presence of NoV antigen in the specimen or control is indicated by colour intensity above background levels. In areas where no laboratory facilities are available there is an increase need for sensitive, rapid and broadly reactive point-of-care assays, such as ICT assays, to allow simple, easy and trustworthynorovirus diagnosis. Molecular kits that can detect multi-gastrointestinal-pathogen in a single sample including norovirus are now available. These tests will be routinely done in many clinical laboratories over the next few of years (11) .
RESULTS

In this work
The present work aimed to study the involvement of norovirus to sporadic cases of pediatric gastroenteritis in Zagazig University Hospitals and to assess the performance characteristics of the IDEIA norovirus assay (Oxoid, UK) together with a second assay, RIDA quick Norovirus Test (R-BioPharm, Darmstadt, Germany), for their capability to detect NoV antigen in faecal samples by comparing the obtained results with RT-PCR results.
In this work 54 out of 200 (27%) samples showed the 338-bp portion of the RdRp gene of both Norovirus genogroups I and II by RT-PCR. In a study done in Egypt by Zaghloul et al. (12) they detected norovirus in 16.2% of stool specimens from the children with gastroenteritis. Kamel et al. (13) studied the circulation of enteric viruses among the population of Cairo, Egypt, they documented that 26% of their samples were positive for norovirus. Lee et al. (14) studied the causative agents in 962 Korean children hospitalized with gastroenteritis they documented that norovirus was detected in 13.7% of the study population.Boga et al. (15) (21) found that IDEIA has sensitivity and specificity of 60.6% and 100% respectively.
In a study done by Duizer et al. (22) they studied the IDEIA (Dakocytomation Ltd., Ely, UK) and they documented a sensitivity of 41% and specificity 98%. Khamrin et al. (23) evaluated the test characteristics of ELISA (Denka). They found a sensitivity 90.4%, specificity 96.4%, PPV 88.0%, NPV 97.2% and accuracy 95.0%. Costantini et al. (6) found that the sensitivity and specificity of the IDEIA Norovirus kit ranged from 57.4% to 77.8% and 79.7% to 91.9%, respectively, when the results were compared by different reference standards.
There are several reasons that could explain the variable sensitivity results. First, collection of samples after onset of symptoms by three days may play a role in lack of detection of NoV (7) . Furthermore, long periods of fecal storage before testing may also affect the level of the virus, as proteolytic degradation may take place (24, 25) .Collection and examination of fecal samples within 72 h after onset of viral gastroenteritis symptoms was done in our study, while in other studies samples were tested after storage for 2 to 3 years (26) . Second, the outcome of all studies may be affected by differences in inclusion criteria fecal samples. Some studies included specimens only when the clinical symptoms indicated a NoV outbreak. On the other hand some studies tested all samples that were sent to the laboratory (24, 25) . Finally, the discrepancy in sensitivity of Rida quick and EIA kit found in different studies may be explained by the antigenic diversity of NoV.Certain genotypes may be missed becausethese kits use monoclonal and polyclonal antibodies formed against virus-like particles representing GI and GII genotypes.
The variable sensitivity of the assays raises serious questions about the usefulness of these kits for routine screening for NoV. Previous studies have also encountered similar falsepositive results with this EIA method (27) . In this work, the nine samples that were negative by RT-PCR, but positive by EIA, also exhibited high absorbance values. The possibility of false negative RT-PCR results should be considered, this may be due to factors that might affect the sensitivity of the RT-PCR assay, e.g., the presence of PCR inhibitors in faecal samples, the instability of viral RNA and the viral genetic diversity (25) .
In countries where the RT-PCR method has not been established for routine diagnosis, ICT RIDA quick Norovirus assay may be helpful for fast screening of norovirus infections in patients with acute gastroenteritis. In contrast, EIA assays investigated in this study was not satisfactorily sensitive to be effective as an exclusive diagnostic method for sporadic cases of NoV-associated acute gastroenteritis, but both tests cannot replacethe RT-PCR method. Routine diagnosis of NoV diarrhoeamay be inadequate due to the lack of a simple reliable test, and many laboratories do not have the facilities to conductRT-PCR. Increasing the sensitivity of EIA method must be considered to become useful as a tool for the diagnosis of NoV diarrhoea in clinical laboratories.
Conclusion
The increasing rates of detection of NoV in pediatric patients suffering from acute gastroenteritis support the inclusion of NoV tests in screening of these patients together with other routine viruses tested.
The Rida quick and IDEIA Norovirus kits may be practical for rapid screening of fecal samples from patients with acute gastroenteritis. Negative samples by these screening kits should be confirmed by a more sensitive and specific technique, such as RT-PCR.
Inclusion of other genogroups in simple, reliable and rapid tests will increase the rates of detection of these viruses.
